Repurposed Medications in Integrative Cancer Therapy
Available Now from Skip’s Pharmacy
Skip’s Pharmacy offers compounded formulations of Mebendazole, Ivermectin, Methylene Blue, and Low Dose Naltrexone (LDN).
- Licensed and experienced in functional medicine support
- Multi-state dispensing and practitioner collaboration.
- Responsive to custom dosing and protocol requests.
Empower Your Cancer & Chronic Care Toolkit with Evidence-Based Repurposed Medications
Functional and integrative medicine practitioners are at the forefront of delivering multidimensional, patient-centered approaches for cancer and chronic diseases. Repurposed medications—such as Mebendazole, Ivermectin, Methylene Blue, and Low Dose Naltrexone (LDN)—offer novel, research-supported strategies that complement existing therapies, modulate fundamental disease pathways, and support whole-person healing.
Discover protocol-ready options, mechanisms, and clinical evidence—all available through Skip’s Pharmacy, a leading compounding pharmacy dedicated to quality and individualized care.
Why Repurposed Medications?
Emerging research and clinical experiences highlight several repurposed drugs for their ability to target cancer’s root drivers: metabolic dysfunction, immune evasion, chronic inflammation, and cancer stem cells. Unlike conventional mono-target therapies, these compounds disrupt multiple signaling pathways, enhance mitochondrial function, support immune surveillance, and may help overcome resistance to standard treatments.
Repurposing established medications leverages decades of pharmacovigilance, cost-effectiveness, and established safety data, while opening new doors to safe, well-tolerated interventions. In integrative and functional medicine, these agents are often combined with nutrition, lifestyle, and metabolic therapies for truly personalized patient plans.
Repurposed Medications with Emerging Promise
Mebendazole
Originally an antiparasitic, mebendazole is gaining attention for its anti-cancer properties.
- Inhibits cancer cell proliferation and induces apopotsis
- Low toxicity profile and oral bloavailability
- Supports metabolic and immune-based
cancer protocols
Ivermectin
Beyond its antiparasitic, use, ivermectin has demonstrated anti-inflammatory, antiviral, and anticancer effects.
- Inhibits cancer cell proliferation and induces apopotsis
- Enhances immune modulation and may synergize with other metabolic therapies
Methylene Blue
A powerful mitochondrial enhancer and antioxidant, methylene blue is being explored for:
- Neuroprotective effects in Alzheimer’s and Parkinson’s
- Adjunctive cancer therapy via mitochondrial modulation
- Mood and cognitive support in treatment-resistant depression
Low Dose Naltrexone
Low Dose Naltrexone (LDN) – Widely used for autoimmune conditions, chronic pain, and inflammation. LDN modulates immune function by transiently blocking opioid receptors, leading to increased endorphin production and immune regulation.
